This week five IPOs debuted, two IPOs updated terms and at the time of this writing…two new IPOs filed.
Royalty Pharma (RPRX) priced 77.7mm shares at $28.00 and opened at $44.00. The stock hit a first week high of $56.50 for a gain of 101.7% at top-tick.
Forma Therapeutics (FMTX) priced 13.8mm shares (upsized from 11.76mm) at $20.00 ($2.00 above range) and opened at $40.00 for a gain of 100% at first trade.
Repare Therapeutics Inc. (RPTX) priced 11.0mm shares (upsized from 10.0mm shares) at $20.00 and opened at $32.05 for a gain of 60.3% at first trade.
Genetron Holdings Limited (GTH) priced 16.0mm ADSs at $16.00 ($2.50 above the $11.50-$13.50 range) and opened at $16.15 for a gain of 0.9 % at first trade. The stock did face selling pressure in its opening session and traded below issue early in its tenure as a public company.
Progenity Inc (PROG) priced a full-size deal, 6.66mm shares, at the midpoint of the range, $15.00 and opened at $15.11 for a gain of 0.7% at first trade. This company was hit with a lawsuit by a competitor in the middle of its roadshow which “may” have spooked investors. The stock did trade below its issue price for much of its opening session.
Looking ahead to the upcoming week, there are two deals currently on the schedule. — Albertsons Holding Company (ACI) and Agora Inc (AGI) and both debut on Friday.
As was the case last week, we are hearing a number of IPOs “could” launch on Monday. Our “projections” of what deals ‘could launch’ on Monday would be:
- Dun & Bradstreet
- Accolade Inc
- Lemonade Inc
- ArcherDx Inc.
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish